| NEWS
by: Motley Rice
The settlement will resolve tens of thousands of women’s claims that Essure caused severe health problems and/or fetal death.
| NEWS
by: Motley Rice
A mid-air collision claimed seven lives in Soldotna, Alaska, on July 31, 2020, including four members of a South Carolina family.
| NEWS
by: Motley Rice
Legal online publication Law360 recognized medical attorney Ann E. Rice Ervin as one of five 2020 Rising Stars in the area of product liability.
| NEWS
by: Motley Rice
A $192 million settlement was approved today to resolve shareholder claims that alleged SCANA Corp. and certain of the energy company’s executives violated the Securities Exchange Act.
| NEWS
by: Motley Rice
Updates to the label for Elmiron®, a medication used to treat bladder pain and inflammation, now warn of potential, permanent damage to the retina that could cause irreversible vision loss.
| NEWS
by: Motley Rice
The U.S. Food and Drug Administration sent a warning letter to Allergan, now AbbVie, reprimanding the medical device manufacturer for serious deficiencies in Allergan’s post-approval studies of its recalled breast implants, which have been linked to an increased risk of cancer.
| NEWS
by: Motley Rice
Recent changes to New Jersey state law in May 2019 that broadened the statute of limitations, or the time in which a person can file a claim, for civil childhood sexual abuse claims are constitutional, Morris County’s Superior Court Judge Paul Bogaard ruled.
| NEWS
by: Motley Rice
New York extended its deadline to file civil sexual abuse claims under the state’s Child Victims Act to Aug. 14, 2021 due to COVID-19.
| NEWS
by: Motley Rice
Litigation concerning claims that the popular antacid medication Zantac causes cancer continues to move forward with U.S. District Judge Robin Rosenberg on May 8, 2020, appointing attorneys to lead the multidistrict litigation, a national consolidation of individual cases.
| NEWS
by: Motley Rice
Thousands of women who allege Johnson & Johnson’s talc-based baby powder caused their ovarian cancer can move forward with claims against the company, a federal judge ruled on April 27.